vs
Side-by-side financial comparison of ACME UNITED CORP (ACU) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $47.7M, roughly 1.1× IRONWOOD PHARMACEUTICALS INC). ACME UNITED CORP runs the higher net margin — 1.9% vs -4.8%, a 6.7% gap on every dollar of revenue. On growth, ACME UNITED CORP posted the faster year-over-year revenue change (13.8% vs -47.3%). Over the past eight quarters, ACME UNITED CORP's revenue compounded faster (-2.9% CAGR vs -20.2%).
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
ACU vs IRWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $47.7M |
| Net Profit | $985.0K | $-2.3M |
| Gross Margin | 39.7% | — |
| Operating Margin | 3.3% | 14.3% |
| Net Margin | 1.9% | -4.8% |
| Revenue YoY | 13.8% | -47.3% |
| Net Profit YoY | -40.4% | -200.9% |
| EPS (diluted) | $0.24 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $52.3M | — | ||
| Q4 25 | $47.5M | $47.7M | ||
| Q3 25 | $49.1M | $122.1M | ||
| Q2 25 | $54.0M | $85.2M | ||
| Q1 25 | $46.0M | $41.1M | ||
| Q4 24 | $45.9M | $90.5M | ||
| Q3 24 | $48.2M | $91.6M | ||
| Q2 24 | $55.4M | $94.4M |
| Q1 26 | $985.0K | — | ||
| Q4 25 | $1.9M | $-2.3M | ||
| Q3 25 | $1.9M | $40.1M | ||
| Q2 25 | $4.8M | $23.6M | ||
| Q1 25 | $1.7M | $-37.4M | ||
| Q4 24 | $1.7M | $2.3M | ||
| Q3 24 | $2.2M | $3.6M | ||
| Q2 24 | $4.5M | $-860.0K |
| Q1 26 | 39.7% | — | ||
| Q4 25 | 38.2% | — | ||
| Q3 25 | 39.1% | — | ||
| Q2 25 | 41.0% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 40.8% | — |
| Q1 26 | 3.3% | — | ||
| Q4 25 | 6.1% | 14.3% | ||
| Q3 25 | 6.1% | 61.8% | ||
| Q2 25 | 11.8% | 53.2% | ||
| Q1 25 | 5.3% | -70.7% | ||
| Q4 24 | 5.0% | 34.8% | ||
| Q3 24 | 6.1% | 28.0% | ||
| Q2 24 | 11.5% | 26.5% |
| Q1 26 | 1.9% | — | ||
| Q4 25 | 3.9% | -4.8% | ||
| Q3 25 | 3.9% | 32.8% | ||
| Q2 25 | 8.8% | 27.7% | ||
| Q1 25 | 3.6% | -90.9% | ||
| Q4 24 | 3.7% | 2.5% | ||
| Q3 24 | 4.6% | 4.0% | ||
| Q2 24 | 8.0% | -0.9% |
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.46 | $0.01 | ||
| Q3 25 | $0.46 | $0.23 | ||
| Q2 25 | $1.16 | $0.14 | ||
| Q1 25 | $0.41 | $-0.23 | ||
| Q4 24 | $0.43 | $0.03 | ||
| Q3 24 | $0.54 | $0.02 | ||
| Q2 24 | $1.09 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $215.5M |
| Total DebtLower is stronger | $33.0M | — |
| Stockholders' EquityBook value | $116.7M | $-261.8M |
| Total Assets | $195.2M | $396.9M |
| Debt / EquityLower = less leverage | 0.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.2M | — | ||
| Q4 25 | $3.6M | $215.5M | ||
| Q3 25 | $5.1M | $140.4M | ||
| Q2 25 | $3.6M | $92.9M | ||
| Q1 25 | $3.4M | $108.5M | ||
| Q4 24 | $6.4M | $88.6M | ||
| Q3 24 | $5.7M | $88.2M | ||
| Q2 24 | $3.8M | $105.5M |
| Q1 26 | $33.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M |
| Q1 26 | $116.7M | — | ||
| Q4 25 | $117.6M | $-261.8M | ||
| Q3 25 | $115.8M | $-264.2M | ||
| Q2 25 | $113.7M | $-308.2M | ||
| Q1 25 | $108.3M | $-334.1M | ||
| Q4 24 | $107.0M | $-301.3M | ||
| Q3 24 | $106.3M | $-311.3M | ||
| Q2 24 | $104.0M | $-321.7M |
| Q1 26 | $195.2M | — | ||
| Q4 25 | $171.0M | $396.9M | ||
| Q3 25 | $173.0M | $396.1M | ||
| Q2 25 | $170.9M | $342.9M | ||
| Q1 25 | $163.0M | $327.2M | ||
| Q4 24 | $162.2M | $350.9M | ||
| Q3 24 | $165.5M | $389.5M | ||
| Q2 24 | $173.5M | $395.6M |
| Q1 26 | 0.28× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $74.6M | ||
| Q3 25 | $7.1M | $47.6M | ||
| Q2 25 | $6.3M | $-15.1M | ||
| Q1 25 | $-3.3M | $20.0M | ||
| Q4 24 | $6.4M | $15.2M | ||
| Q3 24 | $8.9M | $9.9M | ||
| Q2 24 | $6.9M | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | $74.6M | ||
| Q3 25 | $301.0K | $47.6M | ||
| Q2 25 | $4.7M | $-15.1M | ||
| Q1 25 | $-4.7M | $19.9M | ||
| Q4 24 | $4.7M | — | ||
| Q3 24 | $7.5M | $9.9M | ||
| Q2 24 | $4.4M | $33.4M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 156.3% | ||
| Q3 25 | 0.6% | 39.0% | ||
| Q2 25 | 8.7% | -17.7% | ||
| Q1 25 | -10.2% | 48.4% | ||
| Q4 24 | 10.2% | — | ||
| Q3 24 | 15.6% | 10.8% | ||
| Q2 24 | 8.0% | 35.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 0.0% | ||
| Q3 25 | 13.8% | 0.0% | ||
| Q2 25 | 3.0% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 3.7% | 0.0% | ||
| Q3 24 | 2.8% | 0.0% | ||
| Q2 24 | 4.5% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.34× | — | ||
| Q3 25 | 3.72× | 1.19× | ||
| Q2 25 | 1.33× | -0.64× | ||
| Q1 25 | -2.02× | — | ||
| Q4 24 | 3.73× | 6.74× | ||
| Q3 24 | 3.99× | 2.71× | ||
| Q2 24 | 1.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
